Primary vs Secondary Hypogonadism: Diagnosis and Treatment

Fundamental Distinction

Primary hypogonadism (hypergonadotropic) results from testicular dysfunction with low testosterone and elevated LH/FSH, while secondary hypogonadism (hypogonadotropic) results from hypothalamic-pituitary-gonadal axis impairment with low testosterone and low or inappropriately normal LH/FSH. 1, 2

This distinction is critical because it determines both treatment options and fertility potential. 2

Diagnostic Approach

Step 1: Confirm Biochemical Hypogonadism

Measure morning total testosterone (8-10 AM) on two separate occasions, with levels <300 ng/dL (10.5 nmol/L) indicating hypogonadism 1, 2, 3
Measure free testosterone by equilibrium dialysis, especially in obese patients where SHBG alterations may mask true hypogonadism 2, 3
Check sex hormone-binding globulin (SHBG) levels, as low SHBG can artificially lower total testosterone while free testosterone remains normal 2, 3

Step 2: Distinguish Primary from Secondary Hypogonadism

After confirming low testosterone, measure LH and FSH to classify the type: 3, 4

Primary hypogonadism: Elevated LH/FSH with low testosterone indicates testicular failure 1, 2, 5
Secondary hypogonadism: Low or low-normal LH/FSH with low testosterone indicates hypothalamic-pituitary dysfunction 1, 2, 5

Critical pitfall: Never attempt to diagnose the type of hypogonadism while the patient is on testosterone therapy, as exogenous testosterone suppresses gonadotropins and results will be misleading. 2 A 2-4 week washout period is required. 2

Step 3: Identify Specific Symptoms

The European Association of Urology requires both biochemical confirmation and specific symptoms before initiating treatment: 1, 2

More specific symptoms warranting treatment:

Reduced libido 1
Erectile dysfunction 1
Decreased spontaneous/morning erections 1

Less specific symptoms (minimal proven benefit from testosterone):

Fatigue, low energy 1, 2
Decreased physical strength 1
Mood deflection 1

Common Causes by Type

Primary Hypogonadism Causes 1

Acquired:

Chemotherapy or radiation
Bilateral orchitis (mumps, trauma)
Testicular torsion
Klinefelter syndrome (47,XXY)

Congenital:

Cryptorchidism
Myotonic dystrophy
Sickle cell disease

Secondary Hypogonadism Causes 1, 2

Functional (most common):

Obesity (increased aromatization of testosterone to estradiol in adipose tissue causes estradiol-mediated negative feedback suppressing LH) 2
Type 2 diabetes/metabolic syndrome 1
Chronic systemic diseases 1

Drug-induced:

Opiates 1, 2
GnRH agonists/antagonists 1, 2
Glucocorticoids 1, 2
Anabolic steroids 1

Organic:

Pituitary adenoma 1
Kallmann syndrome 1
Idiopathic hypogonadotropic hypogonadism 1
Traumatic brain injury 1
Hyperprolactinemia 1

Treatment Algorithms

For Primary Hypogonadism

Primary hypogonadism patients can ONLY receive testosterone replacement therapy, which permanently compromises fertility by suppressing the HPG axis. 2

First-line treatment: 2, 3

Transdermal testosterone gel 1.62% at 40.5 mg daily (preferred for stable levels)
Alternative: Testosterone cypionate/enanthate 100-200 mg IM every 2 weeks

Monitoring requirements: 2, 3

Testosterone levels at 2-3 months, then every 6-12 months (target 450-600 ng/dL)
Hematocrit periodically—withhold if >54%
PSA in men >40 years
Digital rectal examination

Absolute contraindications: 2, 6

Active desire for fertility (testosterone causes azoospermia)
Active or treated male breast cancer
Hematocrit >54%
Untreated severe obstructive sleep apnea

For Secondary Hypogonadism

The treatment approach for secondary hypogonadism depends entirely on fertility goals, as these patients can potentially achieve both fertility restoration and normal testosterone levels. 2

If Fertility Desired (Mandatory Approach)

Testosterone therapy is ABSOLUTELY CONTRAINDICATED in men seeking fertility. 2, 3

First-line treatment: 2

Gonadotropin therapy: recombinant hCG plus FSH
This directly stimulates the testes, restoring both testosterone production and spermatogenesis
Combined hCG and FSH provides optimal outcomes

If Fertility NOT Desired

Step 1: Address reversible causes first 1, 2

For obesity-associated secondary hypogonadism:

Weight loss through low-calorie diets and regular physical activity can improve testosterone levels without medication 2, 3
This should be attempted before initiating testosterone therapy

For medication-induced hypogonadism:

Discontinue offending agents (opiates, glucocorticoids) if possible 1, 2

Step 2: Testosterone replacement therapy (same regimen as primary hypogonadism) 2, 3

Transdermal testosterone gel 1.62% at 40.5 mg daily (first-line)
Alternative: Testosterone cypionate/enanthate 100-200 mg IM every 2 weeks
Target testosterone levels: 450-600 ng/dL (mid-normal range)

Expected Treatment Outcomes

With Testosterone Therapy 2, 3

Proven benefits:

Small but significant improvements in sexual function and libido (standardized mean difference 0.35)
Modest quality of life improvements, primarily in sexual function domains

Minimal or NO benefit:

Physical functioning, energy, vitality (SMD 0.17)
Depressive symptoms (SMD -0.19)
Cognition
Athletic performance or muscle building in eugonadal men

The European Association of Urology explicitly recommends AGAINST testosterone therapy in eugonadal men, even for weight loss, cardiometabolic improvement, cognition, vitality, or physical strength. 2

With Gonadotropin Therapy (Secondary Hypogonadism) 2

Restoration of both testosterone levels and fertility potential
Direct testicular stimulation bypasses hypothalamic-pituitary dysfunction

Critical Clinical Pitfalls to Avoid

Never start testosterone without confirming the patient does not desire fertility, as it causes prolonged and potentially irreversible azoospermia 2, 3
Never diagnose hypogonadism based on symptoms alone—biochemical confirmation with two morning testosterone measurements is mandatory 1, 2
Never skip measuring LH/FSH after confirming low testosterone, as the distinction between primary and secondary hypogonadism has critical treatment implications 2, 3, 4
Never assume age-related decline in young men—investigate for secondary causes (obesity, medications, pituitary lesions) that may be reversible 2
Never continue testosterone if hematocrit exceeds 54%—this is an absolute indication to withhold therapy and consider phlebotomy 2, 3
Never use testosterone for non-specific symptoms (fatigue, low energy) in men with normal testosterone levels—evidence shows no benefit 2, 3

What are the differences in diagnosis and treatment approaches for primary and secondary hypogonadism?

Help us tailor your experience